Review of the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial: Warfarin versus dabigatran

被引：2
|
作者：
Ingelmo C. [1 ]
Wazni O. [1 ]
机构：
[1] Cleveland Clinic Foundation, Cleveland, OH 44195
来源：
Current Cardiology Reports | 2011年 / 13卷 / 5期
关键词：
Anticoagulation therapy; Atrial fibrillation; Dabigatran; RE-LY trial; Warfarin;
D O I：
10.1007/s11886-011-0203-4
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：357 / 360
页数：3
相关论文
共 50 条
  • [21] Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries An Analysis of Patients Receiving Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
    Van Spall, Harriette G. C.
    Wallentin, Lars
    Yusuf, Salim
    Eikelboom, John W.
    Nieuwlaat, Robby
    Yang, Sean
    Kabali, Conrad
    Reilly, Paul A.
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    [J]. CIRCULATION, 2012, 126 (19) : 2309 - 2316
  • [22] Response to Letter Regarding Article, "Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis"
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Siegbahn, Agneta
    Yusuf, Salim
    Wallentin, Lars
    [J]. CIRCULATION, 2014, 130 (22) : E195 - E195
  • [23] Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
    Eikelboom, John W.
    Wallentin, Lars
    Connolly, Stuart J.
    Ezekowitz, Mike
    Healey, Jeff S.
    Oldgren, Jonas
    Yang, Sean
    Alings, Marco
    Kaatz, Scott
    Hohnloser, Stefan H.
    Diener, Hans-Christoph
    Franzosi, Maria Grazia
    Huber, Kurt
    Reilly, Paul
    Varrone, Jeanne
    Yusuf, Salim
    [J]. CIRCULATION, 2011, 123 (21) : 2363 - U72
  • [24] Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
    Khoo, Chee W.
    Lip, Gregory Y. H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 685 - 687
  • [25] The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
    Reilly, Paul A.
    Lehr, Thorsten
    Haertter, Sebastian
    Connolly, Stuart J.
    Yusuf, Salim
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Nehmiz, Gerhard
    Wang, Susan
    Wallentin, Lars
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (04) : 321 - 328
  • [26] RE-LY trial: both warfarin and dabigatran etexilate reduce GFR
    [J]. Reactions Weekly, 2015, 1558 (1) : 11 - 11
  • [27] Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial
    Boehm, Michael
    Brueckmann, Martina
    Eikelboom, John W.
    Ezekowitz, Michael
    Fraessdorf, Mandy
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Mahfoud, Felix
    Schmieder, Roland E.
    Schumacher, Helmut
    Wallentin, Lars
    Yusuf, Salim
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (30) : 2848 - +
  • [28] Switching patients from warfarin to dabigatran therapy: To RE-LY or not to rely
    Sawaya, Fadi J.
    Musallam, Khaled M.
    Arnaout, Samir
    Rabah, Ali
    Sawaya, Jaber
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 154 (02) : E27 - E28
  • [29] Letter by Chin et al Regarding Article, "Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis"
    Chin, Paul K. L.
    Wright, Daniel F. B.
    Florkowski, Christopher M.
    [J]. CIRCULATION, 2014, 130 (22) : E194 - E194
  • [30] Comparison of Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation: Results from the RE-LY Trial
    Darius, Harald
    Clemens, Andreas
    Healey, Jeff S.
    Avezum, Alvaro
    Nagarakanti, Rangadham
    Chin, Ashley
    Noack, Herbert
    Connolly, Stuart
    [J]. CIRCULATION, 2012, 126 (21)
12345